The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker-Reference-Cited by-同舟云学术

The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker

Author:

Tu Zewei¹²³⁴,Wang Xiaolin⁵,Cai Huan⁶,Sheng Yilei⁷,Wu Lei¹²³⁴,Huang Kai¹²³⁴,Zhu Xingen¹²³⁴

Affiliation:

1. Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi, P.R. China

2. Jiangxi Key Laboratory of Neurological Tumors and Cerebrovascular Diseases, Nanchang 330006, Jiangxi, P.R. China

3. Institute of Neuroscience, Nanchang University, Nanchang 330006, Jiangxi, P.R. China

4. JXHC Key Laboratory of Neurological Medicine, Nanchang 330006, Jiangxi, P.R. China

5. The Second Clinical Medical College of Nanchang University, Nanchang 330006, Jiangxi, P.R. China

6. Department of Medical Ultrasonics, Integrated Chinese and Western Medicine Hospital of Jiangxi Province, Nanchang 330006, Jiangxi, P.R. China

7. The HuanKui Medical College of Nanchang University, Nanchang 330006, Jiangxi, P.R. China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference51 articles.

3. p16.;Chetty;J Clin Pathol,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献